'It's a can of worms': Understanding primary care practitioners' behaviours in relation to HPV using the theoretical domains framework

Implementation Science

Volumn 7, Issue 1, 2012, Pages

  McSherry, Lisa A ^a   Dombrowski, Stephan U ^b   Francis, Jill J ^c   Murphy, Judith ^a   Martin, Cara M ^d   O'Leary, John J ^d   Sharp, Linda ^a  

^a NATIONAL CANCER REGISTRY IRELAND   (Ireland)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

^d Pathology Research Laboratory   (Ireland)

Author keywords

Beliefs about capabilities; Beliefs about consequences; Cervical screening; Clinical behaviours; Emotion; GPs; HPV; Knowledge; Practice nurses; Primary care; Social influences; TDF

Indexed keywords

WART VIRUS VACCINE;

ADULT; ARTICLE; ATTITUDE TO HEALTH; BEHAVIOR; CLINICAL PRACTICE; EMOTION; FEMALE; GENERAL PRACTITIONER; HUMAN; INTERPERSONAL COMMUNICATION; IRELAND; MALE; MIDDLE AGED; NURSE PRACTITIONER; PAPILLOMAVIRUS INFECTION; PROFESSIONAL STANDARD; PSYCHOLOGICAL ASPECT; SOCIAL ENVIRONMENT; UTERINE CERVIX TUMOR; VAGINA SMEAR;

ADULT; BEHAVIOR; COMMUNICATION; EMOTIONS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; IRELAND; MALE; MIDDLE AGED; NURSE PRACTITIONERS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS, PRIMARY CARE; PROFESSIONAL ROLE; SOCIAL ENVIRONMENT; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 84864506160     PISSN: None     EISSN: 17485908     Source Type: Journal    
DOI: 10.1186/1748-5908-7-73     Document Type: Article

References (48)

1. WHO IARC IARC monographs on the evaluation of carcinogenic risks to humans. WHO Press 2007, 90:124. WHO IARC.
2. Bosch FX, Lorincz A, Muñoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002, 55(4):244-265. 10.1136/jcp.55.4.244, 1769629, 11919208.
3. Bosch FX, Burchell AN, Schiffman M, Giuliano AR, de Sanjose S, Bruni L, Tortolero-Luna G, Kjaer SK, Muñoz N. Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine 2008, 26(Suppl 10):K1-K16.
4. Cuzick J, Arbyn M, Sankaranarayanan R, Tsu V, Ronco G, Mayrand MH, Dillner J, Meijer CJ. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Vaccine 2008, 26(Suppl 10):K29-K41.
5. Franceschi S, Denny L, Irwin KL, Jeronimo J, Lopalco PL, Monsonego J, Peto J, Ronco G, Sasieni P, Wheeler CM. Eurogin 2010 roadmap on cervical cancer prevention. Int J Cancer 2011, 128(12):2765-2754. 10.1002/ijc.25915, 21207409.
6. Schiffman M, Wentzensen N, Wacholder S, Kinney W, Gage JC, Castle PE. Human papillomavirus testing in the prevention of cervical cancer. J Natl Cancer Inst 2011, 103(5):368-383. 10.1093/jnci/djq562, 3046952, 21282563.
7. Koliopoulos G, Arbyn M, Martin-Hirsch P, Kyrgiou M, Prendiville W, Paraskevaidis E. Diagnostic accuracy of human papillomavirus testing in primary cervical screening: a systematic review and meta-analysis of non-randomized studies. Gynecol Oncol 2007, 104(1):232-246. 10.1016/j.ygyno.2006.08.053, 17084886.
8. Naucler P, Ryd W, Törnberg S, Strand A, Wadell G, Elfgren K, Rådberg T, Strander B, Forslund O, Hansson BG, Hagmar B, Johansson B, Rylander E, Dillner J. Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening. J Natl Cancer Inst 2009, 101(2):88-99. 10.1093/jnci/djn444, 19141778.
9. Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla Palma P, Del Mistro A, Ghiringhello B, Girlando S, Gillio-Tos A, De Marco L, Naldoni C, Pierotti P, Rizzolo R, Schincaglia P, Zorzi M, Zappa M, Segnan N, Cuzick J, New Technologies for Cervical Cancer screening (NTCC) Working Group Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol 2010, 11(3):249-257. 10.1016/S1470-2045(09)70360-2, 20089449, New Technologies for Cervical Cancer screening (NTCC) Working Group.
10. Vijayaraghavan A, Efrusy MB, Mayrand MH, Santas CC, Goggin P. Cost-effectiveness of high-risk human papillomavirus testing for cervical cancer screening in Québec, Canada. Can J Public Health 2010, 101(3):220-225.
11. Sroczynski G, Schnell-Inderst P, Mühlberger N, Lang K, Aidelsburger P, Wasem J, Mittendorf T, Engel J, Hillemanns P, Petry KU, Krämer A, Siebert U. Cost-effectiveness of primary HPV screening for cervical cancer in Germany - a decision analysis. Eur J Cancer 2011, 47(11):1633-46. 10.1016/j.ejca.2011.03.006, 21482103.
12. Harper DM, Williams KB. Prophylactic HPV vaccines: current knowledge of impact on gynecologic premalignancies. Discov Med 2010, 10(50):7-17.
13. Harper DM, Nieminen P, Paavonen J, Lehtinen M. Cervical cancer incidence can increase despite HPV vaccination. Lancet Infect Dis 2010, 10(9):594-595. 10.1016/S1473-3099(10)70182-1, 20797640.
14. National Cancer Screening Service CervicalCheck. Programme report 2009, http://www.cervicalcheck.ie/_fileupload/File/CervicalCheck%20Programme%20Report%202008-2009.pdf, National Cancer Screening Service.
15. National Immunisation Office Ireland publications:Chapter 6a 2009, http://www.immunisation.ie/en/Downloads/NIACGuidelines/PDFFile_16868_en.pdf, National Immunisation Office Ireland.
16. McCarthy G, Cornally N, Courtney M. The role dimensions, clinical competence, and the professional development of practice nurses. Nurs Gen Pract 2009, 2(6):38-44.
17. Murphy J, Sharp L, Martin C, Pilkington L, Sheils O, O'Leary J. Women's knowledge and attitudes regarding cervical screening and human papillomavirus (HPV): focus group findings from Ireland. Cytopathology 2008, 19(Suppl 2):12.
18. Murphy J, Sharp L, Sheils O, Martin C, Pilkington L, O'Leary J. Irish women's views on cervical screening 2009, HPV infection and HPV vaccination. Finding from a qualitative focus group study, BSCCP conference Dublin.
19. Wright TC, Van Damme P, Schmitt HJ, Meheus A. Chapter 14: HPV vaccine introduction in industrialized countries. Vaccine 2006, 24(Suppl 3):S3/122-131.
20. Abraham C, Sheeran P, Johnston M. From health beliefs to self-regulation: Theoretical advances in the psychology of action control. Psychol Health 1998, 13:569-591.
21. Bonetti D, Johnston M, Pitts NB, Deery C, Ricketts I, Tilley C, Clarkson JE. Knowledge may not be the best target for strategies to influence evidence-based practice: using psychological models to understand RCT effects. Int J Behav Med 2009, 16(3):287-293. 10.1007/s12529-008-9017-1, 19229634.
22. Jain N, Irwin KL, Montano D, Kasprzyk D, Carlin L, Freeman C, Barnes R, Christian J, Wolters C. Family physicians' knowledge of genital human papillomavirus (HPV) infection and HPV-related conditions, United States, 2004. Fam Med 2006, 38(7):483-489.
23. Murphy J, Sharp L, Carsin AE. Attitudes and knowledge of GP's towards Human Papillomavirus infection, testing and vaccination: results from a national survey in Ireland. J Epidemiol Comm Health 2008, 62(Suppl 1):A21-A22.
24. Duval B, Gilca V, McNeil S, Dobson S, Money D, Gemmill IM, Sauvageau C, Lavoie F, Oukki M. Vaccination against human papillomavirus: a baseline survey of Canadian clinicians' knowledge, attitudes and beliefs. Vaccine 2007, 25(45):7841-7847. 10.1016/j.vaccine.2007.08.041, 17923173.
25. Kahn JA, Zimet GD, Bernstein DI, Riedesel JM, Lan D, Huang B, Rosenthal SL. Pediatricians' intention to administer human papillomavirus vaccine: the role of practice characteristics, knowledge, and attitudes. J Adoles Health 2005, 37(6):502-510.
26. Riedesel JM, Rosenthal SL, Zimet GD, Bernstein DI, Huang B, Lan D, Kahn JA. Attitudes about human papillomavirus vaccine among family physicians. J Pediatr Adolesc Gynecol 2005, 18(6):391-398. 10.1016/j.jpag.2005.09.004, 16338604.
27. Songthap A, Pitisuttithum P, Kaewkungwal J, Fungladda W, Bussaratid V, Koonsaeng S. Knowledge, attitudes, and acceptability of a human papillomavirus vaccine among healthcare providers. Southeast Asian J Trop Med Public Health 2009, 40(5):1048-1056.
28. Ajzen I. The theory of planned behavior. Organ Behav Hum Decis Process 1991, 50:179-211.
29. Askelson NM, Campo S, Lowe JB, Dennis LK, Smith S, Andsager J. Factors related to physicians' willingness to vaccinate girls against HPV: the importance of subjective norms and perceived behavioural control. Women Health 2010, 50(2):144-158. 10.1080/03630241003705094, 20437302.
30. Michie S, Johnston M, Abraham C, Lawton R, Parker D, Walker A, Psychological Theory' Group Making psychological theory for implementing evidence based practice: a consensus approach. Qual Saf Health Care 2005, 14(1):26-33. 10.1136/qshc.2004.011155, 1743963, 15692000, Psychological Theory' Group.
31. Francis JJ, O'Connor D, Curran J. Theories of behaviour change synthesised into a set of theoretical groupings: introducing a thematic series on the theoretical domains framework. lmp Sc 2012, 7(1):35.
32. Pope C, Ziebland S, Mays N. Qualitative research in health care. Analysing qualitative data. BMJ 2000, 320(7227):114-116. 10.1136/bmj.320.7227.114, 1117368, 10625273.
33. Ritchie J, Lewis J. Qualitative Research Practice 2003, Sage publications.
34. McCaffery KJ, Waller J, Forrest S, Wardle J. Testing for human papillomavirus in women with abnormal pap smear results. JAMA 2002, 288(11):1350. 10.1001/jama.288.11.1350, 12234220.
35. McCaffery K, Waller J, Forrest S, Casman L, Szarewski A, Wardle J. Testing positive for human papillomavirus in routine cervical screening: examination of psychosocial impact. BJOG 2004, 111(12):1437-1443. 10.1111/j.1471-0528.2004.00279.x, 15663132.
36. Dell DL, Chen H, Ahmad F, Stewart DE. Knowledge about human papillomavirus among adolescents. Obstet Gynecol 2000, 96(5 Pt 1):653-656.
37. Pitts M, Clarke T. Human papillomavirus infections and risks of cervical cancer: what do women know?. Health Educ Res 2002, 17(6):706-714. 10.1093/her/17.6.706, 12507346.
38. Philips Z, Johnson S, Avis M, Whynes DK. Human papillomavirus and the value of screening: young women's knowledge of cervical cancer. Health Educ Res 2003, 18(3):318-328. 10.1093/her/cyf022, 12828233.
39. Waller J, McCaffery K, Forrest S, Szarewski A, Cadman L, Wardle J. Awareness of human papillomavirus among women attending a well woman clinic. Sex Transm Infect 2003, 79(4):320-322. 10.1136/sti.79.4.320, 1744711, 12902585.
40. Anhang R, Wright TCJ, Smock L, Goldie SJ. Women's desired information about human papillomavirus. Cancer 2004, 100(2):315-320. 10.1002/cncr.20007, 14716766.
41. NHS Choices news article http://www.nhs.uk/news/2009/09September/Pages/Cervical-cancer-vaccine-QA.aspx.
42. Gething L, Fethney J. The need for disability awareness training among rurally based Australian general medical practitioners. Disabil Rehabil 1997, 19(6):249-259. 10.3109/09638289709166535, 9195143.
43. Agarwal G, Pierce M, Ridout D. The GP perspective: problems experienced in providing diabetes care in UK general practice. Diabet Med 2002, 19(Suppl 4):13-20.
44. Defty H, Smith H, Kennedy M, Perry N, Fisher M. GPs' perceived barriers to their involvement in caring for patients with HIV: a questionnaire-based study. Br J Gen Pract 2010, 60(574):348-351. 10.3399/bjgp10X501840, 2858532, 20423586.
45. Medical Research Council A framework for the development and evaluation of randomised controlled trials for complex interventions to improve health. BMJ 2000, 321(7262):694-696. 10.1136/bmj.321.7262.694, 1118564, 10987780, Medical Research Council.
46. Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M, Medical Research Council Guidance Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ 2008, 337:a1655. 10.1136/bmj.a1655, 2769032, 18824488, Medical Research Council Guidance.
47. Byrne M, Cupples ME, Smith SM, Leathem C, Corrigan M, Byrne MC, Murphy AW. Development of a complex intervention for secondary prevention of coronary heart disease in primary care using the UK Medical Research Council framework. Am J Manag Care 2006, 12(5):261-266.
48. Francis JJ, Stockton C, Eccles MC, Johnston M, Cuthbertson BH, Grimshaw JM, Hyde C, Tinmouth A, Stanworth SJ. Evidence-based selection of theories for designing behaviour change interventions: using methods based on theoretical construct domains to understand clinicians' blood transfusion behaviour. Br J Health Psychol 2009, 14(Pt 4):625-646.